Similar companies
| Company | Business Outlook | |
|---|---|---|
 |
AmgenAMGN |
77 1.3% |
 |
Gilead SciencesGILD |
57 0% |
 |
Catalyst PharmaceuticalsCPRX |
100 0% |
 |
Inovio PharmaceuticalsINO |
23 0% |
 |
Anavex Life SciencesAVXL |
0 0% |
Month over Month
Employee view on business outlook (0 - 100)
| Oct 2024 | 58 | |
| Sep 2024 | 65 | |
| Jul 2024 | 64 |
How do employees feel about the future at 10X Genomics?
The Business Outlook at 10X Genomics is neutral, according to employees. The average rating, aggregated from the top review sites in the US, of 65 out of 100 is decent. The rating is up, compared to previous month.
Analyzing Business Outlook, how is 10X Genomics performing compared to its industry peers?
10X Genomics overperforms a majority of its industry peers when it comes to Business Outlook, ranking in the 65th percentile.
Why is it important to track the business outlook at 10X Genomics?
Tracking a company's business outlook is important as a positive outlook can indicate future growth and profitability and attract new talent, while a negative outlook can discourage talent and imply demotivated employees. Additionally, data shows that companies with a high business outlook tend to perform better on the stock market compared to those with a lower business outlook.
Sign up and get more insights on the business outlook at 10X Genomics.
